FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.7.4-SNAPSHOT  |  FHIR Version n/a  User: [n/a]

374086008: Clindamycin palmitate hydroc 75 mg/ 5mL suspension (product)


    Status: retired, Not sufficiently defined by necessary conditions definition status (core metadata concept). Date: 31-Jul 2008. Module: SNOMED CT core

    Descriptions:

    Id Description Lang Type Status Case? Module
    1199387014 Clindamycin palmitate hydroc 75 mg/ 5mL suspension (product) en Fully specified name Active Only initial character case insensitive (core metadata concept) SNOMED CT core
    1212527015 Clindamycin palmitate hydroc 75 mg/ 5mL suspension en Synonym (core metadata concept) Active Only initial character case insensitive (core metadata concept) SNOMED CT core
    1199387014 Clindamycin palmitate hydroc 75 mg/ 5mL suspension (product) en Fully specified name Active Only initial character case insensitive (core metadata concept) SNOMED CT core
    1212527015 Clindamycin palmitate hydroc 75 mg/ 5mL suspension en Synonym (core metadata concept) Active Only initial character case insensitive (core metadata concept) SNOMED CT core


    0 descendants.

    Expanded Value Set


    Outbound Relationships Type Target Active Characteristic Refinability Group Values
    Clindamycin palmitate hydroc 75 mg/ 5mL suspension Is a Clindamycin-containing product false Inferred relationship Existential restriction modifier (core metadata concept)
    Clindamycin palmitate hydroc 75 mg/ 5mL suspension The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. Local anti-infective false Inferred relationship Existential restriction modifier (core metadata concept)
    Clindamycin palmitate hydroc 75 mg/ 5mL suspension The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. Clindamycin palmitate hydrochloride false Inferred relationship Existential restriction modifier (core metadata concept)
    Clindamycin palmitate hydroc 75 mg/ 5mL suspension The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. Substance with macrolide structure and antibacterial mechanism of action (substance) false Inferred relationship Existential restriction modifier (core metadata concept)
    Clindamycin palmitate hydroc 75 mg/ 5mL suspension Is a Clindamycin-containing product in oral dose form false Inferred relationship Existential restriction modifier (core metadata concept)
    Clindamycin palmitate hydroc 75 mg/ 5mL suspension Has manufactured dose form Oral suspension (product) false Inferred relationship Existential restriction modifier (core metadata concept)
    Clindamycin palmitate hydroc 75 mg/ 5mL suspension The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. Bactericide false Inferred relationship Existential restriction modifier (core metadata concept)

    Inbound Relationships Type Active Source Characteristic Refinability Group

    Reference Sets

    Concept inactivation indicator attribute value reference set (foundation metadata concept)

    REPLACED BY association reference set (foundation metadata concept)

    Back to Start